8 results
Recent studies have revealed many attractive therapeutic options, even if some of them remain to be
preclinical models and clinical ... trials #covid19 ... #sarscov2 #management ... #treatment #coronavirus ... #medications
Diagnostic approach to the admitted patient with possible COVID-19

Initial evaluation
- Chest X-ray
- Lung ultrasound (thorough "lawn-mower"
with possible COVID ... Chest X-ray - Lung ... diagnostics as clinically ... #algorithm #schema ... #Diagnosis #SARSCoV2
Possible Approach to Immunosuppression in Severe COVID-19

The diagnosis and treatment of cytokine storm remains unknown and
diagnosis and treatment ... Internet Book of Critical ... #management #schema ... #criticalcare #algorithm ... #SARSCOV2 #Coronavirus
General schema for respiratory support in patients with COVID-19
Low flow nasal cannula
 • Typically set at
General schema for ... patients with COVID ... Internet Book of Critical ... #management #schema ... hypoxia #failure #algorithm
COVID-19 Intubation Checklist

Personal protective equipment (PPE)
 • Standard PPE
   • N95 or PAPR.
COVID-19 Intubation ... Checklist Personal ... Medications & pre-planned ... #Intubation #Checklist ... #SARSCoV2 #Management
Possible approach to empiric anticoagulation in COVID-19

Is D-dimer above '"1,000-2,000 ng/ml?
Contraindication to anticoagulation?
Check fibrinogen level and/or
anticoagulation in COVID ... Internet Book of Critical ... #management #schema ... #criticalcare #algorithm ... #SARSCOV2 #Coronavirus
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Organizing Pneumonia - Clinical ... History: cough, dyspnea ... with diff • Chem ... Organizing Pneumonia Treatment ... ILD #diagnosis #management
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
effects in the treatment ... Weaknesses: Limited clinical ... fever, chills, dyspnea ... Antifungal #agents #medications ... #pharmacology #management